Talaris Therapeutics, Inc. launches an IPO.
IPO of Talaris Therapeutics, Inc. (TALS) will take place on May 6, 2021. Talaris Therapeutics is a late-clinical stage, cell therapy company that develops an innovative method of allogeneic hematopoietic stem cell transplantation (allo-HSCT).